Durect Corp (DRRX)

$2.28 0.02 (1.09%)

12:26 EST DRRX Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 367.89M

PE Ratio -113.75

EPS -0.02

Volume (Avg. Vol.) 445,517

Day's Range 2.13 - 2.28

52-Week Range 0.95 - 2.96

Dividend & Yield N/A (N/A)

DRRX Stock Predictions, Articles, and Durect Corp News

From InvestorPlace
From the Web

7 Penny Stocks to Buy Right Now As Trends Catalyze Opportunity

By Alex Sirois Aug 20, 2020

As we head further into August, a handful of penny stocks look like good opportunities. That said, here's seven penny stocks to buy.

5 Stocks Under $5 With Colossal Growth Prospects

By Maya Sasson, Writer, TipRanks Jan 31, 2020

While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.

First Week of DRRX February 2021 Options Trading

From Market News Video Dec 18, 2020

Investors in Durect Corp (DRRX) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DRRX options chain for the new February 2021 contracts and identified the following call contract of particular interest.

80 Biggest Movers From Yesterday

From Benzinga Dec 18, 2020

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 473.7% to close at $33.96 on Thursday. Scopus BioPharma’s filing showed registration for 500,000 share common...

Durect (DRRX) Received its Third Buy in a Row

From Smarter Analyst Dec 8, 2020

After Chardan Capital and H.C. Wainwright gave Durect (NASDAQ: DRRX) a Buy rating last month, the company received another Buy, this time from

The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations

From Benzinga Nov 13, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) ALX Oncology Holdings Inc (...

The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions

From Benzinga Nov 8, 2020

Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of guard at the White House. The...

54 Biggest Movers From Yesterday

From Benzinga Nov 4, 2020

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) climbed 78.3% to close at $11.23 on Tuesday after the company issued an update on its ongoing APVO436 Phase 1 clinical trial....

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold